Here we demonstrated that IL-11 was produced as a soluble factor in the tumour microenvironment of patients with colon cancer (Fig. 5a,b) and promoted the differentiation of immune cells into functional MDSCs (Fig. 2). The gene discussed is IL11; the disease is malignant colon neoplasm.